Cocrystal Pharma (COCP) Q4 2025 Annual Earnings
COCP·Reported May 21, 2026·Before market open
Diluted EPS came in at $-0.16 (+50.0% YoY), missed the $-0.15 consensus by $0.01.
Diluted EPS
$-0.16missed by $0.01
Consensus: $-0.15
Financial Snapshot
Trailing eight quarters through Q4 2025
Q4 2025 Earnings FAQ
Common questions about Cocrystal Pharma's Q4 2025 earnings report.
Cocrystal Pharma (COCP) reported Q4 2025 earnings on May 21, 2026 before market open.
Cocrystal Pharma reported diluted EPS of $-0.16 for Q4 2025.
EPS missed the consensus estimate of $-0.15 by $0.01.
Compared to the same quarter a year prior, diluted EPS grew 50.0% from $-0.32.
You can read the 10-K periodic report (0001493152-26-013838) directly on SEC EDGAR. The filing index links above go to sec.gov.